Flexible ureteroscopy lithotripsy (FURS) is the most common treatment for patients with upper urinary tract calculi (diameter, <2 cm). The purpose of this prospective study was to assess the efficacy of FURS combined with metallic ureteral stents (MUS) for the treatment of upper
urinary tract calculi. A total of 38 patients with upper urinary tract calculi were recruited in the present study, to compare the efficacy between FURS and FURS combined with MUS (FURSMUS). The results demonstrated that FURSMUS shortened operative time compared with FURS (35.2±1.2
vs. 57.4±1.7 min, respectively; P<0.01). Data also indicated that the clearance rate in FURSMUS and FURS was decreased from 94.5 and 87.8%, respectively (P<0.05). FURSMUS treatment decreased the duration of postoperative hospital stay compared with FURS (4.5±0.5
vs. 7.5±1.5 days, respectively; P<0.05). These data demonstrated that FURSMUS significantly increased postoperative inflammation score compared with FURS (6.2±0.8 vs. 4.2±1.0, respectively; P<0.05). The complication rate and blood loss exhibited no significant
difference between FURSMUS and FURS (complication rate, 6.5% vs. 5.9%, respectively; blood loss, 4.2% vs. 4.6%, respectively). FURSMUS significantly decreased inflammatory cytokines and risk of sepsis, and improved readmission rate, stone recurrence and progressionfree survival compared with
patients treated with FURS. In conclusion, these data suggested that FURSMUS may be an efficient, minimally invasive and reproducible operation for patients with upper urinary tract calculi.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510700, P.R. China
Department of Urology, The First Affiliated Hospital of Sun YatSen University, Guangzhou, Guangdong 510080, P.R. China
October 1, 2020
More about this publication?
Experimental and Therapeutic Medicine aims to ensure the expedient publication, in both print and electronic format, of studies relating to biology, gene therapy, infectious disease, microbiology, molecular cardiology and molecular surgery. The journal welcomes studies pertaining to all aspects of molecular medicine, and studies relating to in vitro or in vivo experimental model systems relevant to the mechanisms of disease are also included.
All materials submitted to this journal undergo the appropriate review via referees who are experts in this field. All materials submitted follow international guidelines with regard to approval of experiments on humans and animals.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites